Back

A Highly Efficient Aorta-Gonad-Mesonephros-Like Definitive Hemogenic Endothelium From Human Pluripotent Stem Cells

Fstkchyan, Y.; Cheng, Q.; Zhang, J. A.; Lu, D.; Huang, G.; Dong, T.; Jones, L.; Kanke, M.; Hale, C.; Tarbell, K.; Li, C.-M. K.; Wang, S.; Chambers, S.

2023-06-26 developmental biology
10.1101/2023.06.26.546545 bioRxiv
Show abstract

Summary/AbstractHuman pluripotent stem cells are a tremendous tool to model early human development and disease including their use in the in vitro generation of blood cell fates. Hematopoietic progenitors and stem cells are the primary source of blood and the immune system from early development to adulthood and arise through successive waves of hemogenic mesoderm either in the yolk sac or embryo proper. Researchers have long sought a tractable human model for observing and distinguishing these waves of hematopoiesis in the dish for human developmental and disease modeling. Here we report a high-efficiency method for differentiating human pluripotent stem cells into an aorta-gonad-mesonephros-like definitive hemogenic mesoderm capable of giving rise to definitive hematopoietic progenitor and stem cells. The hematopoietic progenitor and stem cells exhibit robust multilineage in vitro colony forming potential. Gene expression analysis and single cell sequencing strongly support the developmental timing and notion that the pluripotent stem cell derived hematopoietic stem and progenitors are strikingly like bone fide hematopoietic stem cells. The hematopoietic progenitors can be subsequently differentiated into polarized macrophage and T-cells in vitro. Minimal silencing was observed upon differentiation of the pluripotent stem cells to hematopoietic lineages when conducting gene editing. Finally, upon engraftment into immunodeficient animals the hematopoietic progenitors and stem cells differentiate into multiple lineages including B-cells, T-cells, NK-cells, and monocytes.

Matching journals

The top 4 journals account for 50% of the predicted probability mass.

1
Stem Cells
31 papers in training set
Top 0.1%
19.2%
2
Stem Cell Reports
130 papers in training set
Top 0.1%
19.2%
3
Blood Advances
62 papers in training set
Top 0.2%
8.2%
4
Nature Communications
5641 papers in training set
Top 25%
6.5%
50% of probability mass above
5
Scientific Reports
3612 papers in training set
Top 25%
4.2%
6
Experimental Hematology
11 papers in training set
Top 0.1%
4.2%
7
Stem Cells Translational Medicine
13 papers in training set
Top 0.1%
3.6%
8
eLife
5828 papers in training set
Top 32%
3.3%
9
PLOS ONE
5266 papers in training set
Top 41%
2.5%
10
Science Advances
1243 papers in training set
Top 14%
2.5%
11
Cell Reports
1498 papers in training set
Top 16%
2.2%
12
iScience
1154 papers in training set
Top 16%
1.8%
13
Molecular Therapy
81 papers in training set
Top 0.8%
1.8%
14
npj Regenerative Medicine
24 papers in training set
Top 0.4%
1.6%
15
Cell Stem Cell
62 papers in training set
Top 1%
1.4%
16
Stem Cell Research
16 papers in training set
Top 0.2%
1.2%
17
Stem Cell Research & Therapy
30 papers in training set
Top 0.6%
1.0%
18
Communications Biology
993 papers in training set
Top 27%
1.0%
19
Development
497 papers in training set
Top 4%
1.0%
20
Molecular Therapy - Methods & Clinical Development
38 papers in training set
Top 0.6%
0.9%
21
Blood
74 papers in training set
Top 1%
0.9%
22
Cell Reports Methods
165 papers in training set
Top 4%
0.6%
23
Clinical & Translational Immunology
22 papers in training set
Top 0.4%
0.6%
24
Frontiers in Cell and Developmental Biology
233 papers in training set
Top 6%
0.5%
25
Molecular Therapy - Nucleic Acids
25 papers in training set
Top 0.9%
0.5%
26
Biology Open
156 papers in training set
Top 5%
0.5%
27
Genome Biology
637 papers in training set
Top 10%
0.5%
28
Proceedings of the National Academy of Sciences
2444 papers in training set
Top 46%
0.5%